Device for Bladder Control for Men With SCI
Noninvasive Electrical Stimulation Device to Improve Bladder Control for Men With Spinal Core Injury
研究概览
详细说明
Urinary incontinence, bladder frequency, and bladder urgency are significant medical problems for people with overactive bladder (OAB) or neurogenic bladder overactivity (NDO). Restoring bladder control is considered a high priority, but remains a critically unmet need requiring further development. The long-term goal is to develop and clinically implement a "bladder pacemaker" able to restore bladder control for individuals with OAB or NDO. Electrical stimulation of the genital nerves inhibits the spinal neural circuits involved in hyper-reflexive bladder spasms.
Genital nerve stimulation (GNS) has been used by multiple groups to inhibit reflexive OAB and neurogenic bladder contractions during acute (1 visit) urodynamic testing and limited chronic take-home testing. The investigators have recently demonstrated that surface GNS inhibits reflexive bladder contractions and reduces incontinence in individuals with SCI during one month of home use using a limited stimulation system. Participant feedback from these studies identified a number of stimulation system issues that created nontrivial inconveniences, which affected activities of daily living and prevented some participants from participating in the study. Required improvements include, but are not limited to better electrode interface, elimination of wired connections, and a smaller device.
The purposes of this proposal are to 1) develop and prototype a device for bladder control for men using GNS and 2) determine the acute effect of GNS on bladder capacity using this new prototype device. This work is building on previous success prototyping a similar device for women with OAB or NDO, which is being developed in other projects. The success of this study will be used to conduct a multi-site study of GNS and lead to clinical implementation.
研究类型
注册 (估计的)
阶段
- 阶段2
- 阶段1
联系人和位置
学习联系方式
- 姓名:Dennis Bourbeau, PhD
- 电话号码:4845 (216) 791-3800
- 邮箱:Dennis.Bourbeau@va.gov
学习地点
-
-
Ohio
-
Cleveland、Ohio、美国、44106-1702
- Louis Stokes VA Medical Center, Cleveland, OH
-
首席研究员:
- Dennis Bourbeau, PhD
-
接触:
- Curtis J Donskey, MD
- 电话号码:4788 (216) 791-3800
- 邮箱:curtis.donskey@va.gov
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Suprasacral SCI
- Neurologically stable
- Skeletally mature
- Presence of reflex bladder contractions
- At least 12 months post SCI
Exclusion Criteria:
- Active sepsis
- Open pressure sores on or around pelvis
- Bleeding diathesis
- Significant urethral trauma, erosion, or stricture
- Indwelling catheter for over 1 year AND bladder capacity less than 100 mL
- Significant history of autonomic dysreflexia
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Genital Nerve Stimulation
Study participants will don the device at the beginning of the experiment session.
An initial clinical urodynamics test will be performed to confirm that the participant has neurogenic bladder.
The investigators will select stimulation parameters that effectively inhibit reflexive bladder contractions.
Serial cystometrograms will then be conducted.
Each fill will be conducted either 1) without stimulation (control runs) or 2) with stimulation.
|
Genital nerve stimulation (GNS) will be applied using a wearable, transcutaneous neurostimulator and sleeve electrode that targets the genital nerve reflex pathway for the treatment of neurogenic bladder associated with spinal cord injury.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Bladder Capacity
大体时间:Day 1
|
Change in bladder capacity (in mL) in response to genital nerve stimulation will serve as the primary outcome measure for this study.
|
Day 1
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Usability Metrics
大体时间:Day 1
|
Study participants will be surveyed regarding device design and usability prior to device usage.
|
Day 1
|
|
Electrical Impedance
大体时间:Day 1
|
The Gravata's electrode to skin contact will be assessed through measuring electrical impedance of the device to confirm adherence to out benchmark (less than 4 kOhms)
|
Day 1
|
合作者和调查者
调查人员
- 首席研究员:Dennis Bourbeau, PhD、Louis Stokes VA Medical Center, Cleveland, OH
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- RRD5-001-25W
- IU1RD000568-01A2 (其他赠款/资助编号:VA ORD)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
在美国制造并从美国出口的产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.